12-13564574-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000834.5(GRIN2B):​c.2664C>T​(p.Thr888Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.284 in 1,613,394 control chromosomes in the GnomAD database, including 69,306 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5287 hom., cov: 32)
Exomes 𝑓: 0.29 ( 64019 hom. )

Consequence

GRIN2B
NM_000834.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: -1.59

Publications

104 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 12-13564574-G-A is Benign according to our data. Variant chr12-13564574-G-A is described in ClinVar as Benign. ClinVar VariationId is 98437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.59 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.493 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000834.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
NM_000834.5
MANE Select
c.2664C>Tp.Thr888Thr
synonymous
Exon 14 of 14NP_000825.2Q13224
GRIN2B
NM_001413992.1
c.2664C>Tp.Thr888Thr
synonymous
Exon 15 of 15NP_001400921.1A0A8D9PHB2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
ENST00000609686.4
TSL:1 MANE Select
c.2664C>Tp.Thr888Thr
synonymous
Exon 14 of 14ENSP00000477455.1Q13224
GRIN2B
ENST00000630791.3
TSL:5
c.2664C>Tp.Thr888Thr
synonymous
Exon 15 of 15ENSP00000486677.3A0A0D9SFK0
GRIN2B
ENST00000637214.1
TSL:5
c.69+44029C>T
intron
N/AENSP00000489997.1A0A1B0GU78

Frequencies

GnomAD3 genomes
AF:
0.246
AC:
37346
AN:
151914
Hom.:
5282
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.104
Gnomad AMI
AF:
0.291
Gnomad AMR
AF:
0.286
Gnomad ASJ
AF:
0.332
Gnomad EAS
AF:
0.509
Gnomad SAS
AF:
0.401
Gnomad FIN
AF:
0.367
Gnomad MID
AF:
0.215
Gnomad NFE
AF:
0.268
Gnomad OTH
AF:
0.261
GnomAD2 exomes
AF:
0.316
AC:
79410
AN:
251050
AF XY:
0.320
show subpopulations
Gnomad AFR exome
AF:
0.0991
Gnomad AMR exome
AF:
0.329
Gnomad ASJ exome
AF:
0.333
Gnomad EAS exome
AF:
0.523
Gnomad FIN exome
AF:
0.372
Gnomad NFE exome
AF:
0.271
Gnomad OTH exome
AF:
0.311
GnomAD4 exome
AF:
0.289
AC:
421632
AN:
1461362
Hom.:
64019
Cov.:
39
AF XY:
0.292
AC XY:
212222
AN XY:
727022
show subpopulations
African (AFR)
AF:
0.0967
AC:
3238
AN:
33476
American (AMR)
AF:
0.323
AC:
14449
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.335
AC:
8764
AN:
26132
East Asian (EAS)
AF:
0.495
AC:
19652
AN:
39696
South Asian (SAS)
AF:
0.409
AC:
35253
AN:
86232
European-Finnish (FIN)
AF:
0.365
AC:
19460
AN:
53350
Middle Eastern (MID)
AF:
0.262
AC:
1511
AN:
5766
European-Non Finnish (NFE)
AF:
0.271
AC:
301502
AN:
1111606
Other (OTH)
AF:
0.295
AC:
17803
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
17102
34204
51307
68409
85511
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10246
20492
30738
40984
51230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.246
AC:
37355
AN:
152032
Hom.:
5287
Cov.:
32
AF XY:
0.256
AC XY:
19005
AN XY:
74304
show subpopulations
African (AFR)
AF:
0.104
AC:
4313
AN:
41502
American (AMR)
AF:
0.286
AC:
4371
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.332
AC:
1151
AN:
3470
East Asian (EAS)
AF:
0.509
AC:
2608
AN:
5122
South Asian (SAS)
AF:
0.401
AC:
1930
AN:
4816
European-Finnish (FIN)
AF:
0.367
AC:
3879
AN:
10558
Middle Eastern (MID)
AF:
0.197
AC:
58
AN:
294
European-Non Finnish (NFE)
AF:
0.268
AC:
18221
AN:
67958
Other (OTH)
AF:
0.265
AC:
559
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1415
2831
4246
5662
7077
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.259
Hom.:
13216
Bravo
AF:
0.235
Asia WGS
AF:
0.432
AC:
1499
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
3
not provided (4)
-
-
1
Inborn genetic diseases (1)
-
-
1
Intellectual disability, autosomal dominant 6;C4015316:Developmental and epileptic encephalopathy, 27 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
6.1
DANN
Benign
0.71
PhyloP100
-1.6
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1806201; hg19: chr12-13717508; COSMIC: COSV74206013; COSMIC: COSV74206013; API